menu search

Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September

Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
WILMINGTON, Del., Aug. 29, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will participate in three upcoming healthcare investment conferences. Details are as follows: Wells Fargo 18th Annual Healthcare Conference Boston Kris Vaddi, Ph.D., Chief Executive Officer will participate in a Fireside chat […] The post Prelude Therapeutics to Participate in Three Healthcare Investor Conferen... Read More
Posted: Aug 29 2023, 12:30
Author Name: forextv
Views: 111692

Search within

Pages Search Results: